TW200734638A - Method for the diagnosis of thromboembolic and coronary heart diseases - Google Patents
Method for the diagnosis of thromboembolic and coronary heart diseasesInfo
- Publication number
- TW200734638A TW200734638A TW095136992A TW95136992A TW200734638A TW 200734638 A TW200734638 A TW 200734638A TW 095136992 A TW095136992 A TW 095136992A TW 95136992 A TW95136992 A TW 95136992A TW 200734638 A TW200734638 A TW 200734638A
- Authority
- TW
- Taiwan
- Prior art keywords
- thromboembolic
- coronary heart
- heart diseases
- diagnosis
- egln2 protein
- Prior art date
Links
- 208000001435 Thromboembolism Diseases 0.000 title abstract 2
- 208000029078 coronary artery disease Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000009424 thromboembolic effect Effects 0.000 title abstract 2
- 101000881650 Homo sapiens Prolyl hydroxylase EGLN2 Proteins 0.000 abstract 2
- 102000048660 human EGLN2 Human genes 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005048899A DE102005048899A1 (de) | 2005-10-12 | 2005-10-12 | Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200734638A true TW200734638A (en) | 2007-09-16 |
Family
ID=37684083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095136992A TW200734638A (en) | 2005-10-12 | 2006-10-05 | Method for the diagnosis of thromboembolic and coronary heart diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20090197774A1 (OSRAM) |
| EP (1) | EP1937839B1 (OSRAM) |
| JP (1) | JP2009511026A (OSRAM) |
| KR (1) | KR20080052662A (OSRAM) |
| CN (1) | CN101287846A (OSRAM) |
| AR (1) | AR056125A1 (OSRAM) |
| AT (1) | ATE525481T1 (OSRAM) |
| AU (1) | AU2006301578B9 (OSRAM) |
| BR (1) | BRPI0617341A2 (OSRAM) |
| CA (1) | CA2625698A1 (OSRAM) |
| DE (1) | DE102005048899A1 (OSRAM) |
| IL (1) | IL190585A (OSRAM) |
| TW (1) | TW200734638A (OSRAM) |
| WO (1) | WO2007042165A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005048898A1 (de) * | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| EP2311981B1 (en) | 2007-05-01 | 2014-09-17 | The Regents of The University of California | Methods for diagnosing ischemia |
| EP2593566B1 (en) | 2010-07-14 | 2018-01-24 | The Regents of The University of California | Biomarkers for diagnosis of transient ischemic attacks |
| CA2804802C (en) | 2010-07-15 | 2023-03-07 | The Regents Of The University Of California | Biomarkers for diagnosis of stroke and its causes |
| US20120316076A1 (en) | 2011-03-04 | 2012-12-13 | The Regents Of The University Of California | Biomarkers for the diagnosis of lacunar stroke |
| CN104094121B (zh) | 2011-12-01 | 2016-10-26 | 霍夫曼-拉罗奇有限公司 | 用于诊断中风的nt-原anp和nt-原bnp |
| WO2013103781A1 (en) | 2012-01-07 | 2013-07-11 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
| KR101939778B1 (ko) | 2012-07-27 | 2019-01-18 | 삼성전자주식회사 | 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치 |
| CN119846215B (zh) * | 2025-01-22 | 2025-07-11 | 广西医科大学附属肿瘤医院 | Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482117B2 (en) * | 2002-12-20 | 2009-01-27 | Celera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| US7306913B2 (en) * | 2002-12-20 | 2007-12-11 | Applera Corporation | Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof |
-
2005
- 2005-10-12 DE DE102005048899A patent/DE102005048899A1/de not_active Withdrawn
-
2006
- 2006-09-30 AT AT06792341T patent/ATE525481T1/de active
- 2006-09-30 CA CA002625698A patent/CA2625698A1/en not_active Withdrawn
- 2006-09-30 JP JP2008534895A patent/JP2009511026A/ja not_active Abandoned
- 2006-09-30 EP EP06792341A patent/EP1937839B1/de not_active Not-in-force
- 2006-09-30 CN CNA2006800376009A patent/CN101287846A/zh active Pending
- 2006-09-30 WO PCT/EP2006/009517 patent/WO2007042165A1/de not_active Ceased
- 2006-09-30 KR KR1020087008790A patent/KR20080052662A/ko not_active Withdrawn
- 2006-09-30 AU AU2006301578A patent/AU2006301578B9/en not_active Withdrawn - After Issue
- 2006-09-30 BR BRPI0617341-1A patent/BRPI0617341A2/pt not_active Application Discontinuation
- 2006-09-30 US US12/089,624 patent/US20090197774A1/en not_active Abandoned
- 2006-10-05 TW TW095136992A patent/TW200734638A/zh unknown
- 2006-10-10 AR ARP060104446A patent/AR056125A1/es unknown
-
2008
- 2008-04-02 IL IL190585A patent/IL190585A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0617341A2 (pt) | 2011-07-26 |
| EP1937839A1 (de) | 2008-07-02 |
| JP2009511026A (ja) | 2009-03-19 |
| DE102005048899A1 (de) | 2007-04-19 |
| IL190585A (en) | 2011-12-29 |
| WO2007042165A1 (de) | 2007-04-19 |
| US20090197774A1 (en) | 2009-08-06 |
| AU2006301578A1 (en) | 2007-04-19 |
| CA2625698A1 (en) | 2007-04-19 |
| AR056125A1 (es) | 2007-09-19 |
| AU2006301578B9 (en) | 2011-12-22 |
| ATE525481T1 (de) | 2011-10-15 |
| EP1937839B1 (de) | 2011-09-21 |
| IL190585A0 (en) | 2008-11-03 |
| KR20080052662A (ko) | 2008-06-11 |
| CN101287846A (zh) | 2008-10-15 |
| AU2006301578B2 (en) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004092405A3 (en) | Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof | |
| WO2005014035A3 (en) | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest | |
| WO2004006838A3 (en) | Novel kinases | |
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| WO2008093165A3 (en) | The use of pgil ohgosaccharyltransferase for o-glycosylating proteins | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
| WO2004076614A3 (de) | Humane nukleinsäuresequenzen aus prostatakarzinomen | |
| AR056125A1 (es) | Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas | |
| NO20070780L (no) | Celloverflateprotein. | |
| DE50115042D1 (de) | Mutanten der den Faktor VII aktivierenden Protease und Nachweisverfahren mit spezifischen Antikörpern | |
| WO2003012099A1 (fr) | Synthase de chondroitine | |
| TW200724679A (en) | Treatment of disease using an improved regulated expression system | |
| WO2003025010A3 (en) | Human delta-n p73 molecules and uses thereof | |
| WO2005110460A3 (en) | Diagnosis and treatment methods related to aging, especially in muscle (14.1) | |
| WO2008126517A1 (ja) | 哺乳動物における新規ｓｌｃ１７型トランスポータータンパク質およびその利用 | |
| DE60336596D1 (de) | Ortspezifische verabreichung von aktiven substanzen im darm | |
| DE602005019421D1 (de) | Grosstechnisch geeigneter mikroorganismus | |
| WO2004076613A3 (de) | Humane nukleinsäuresequenzen aus harnblasenkarzinomen | |
| WO2002086067A3 (en) | Mycobacterial sulfation pathway proteins and methods of use thereof | |
| WO2008014296A3 (en) | Composition and method for treatment of tumors | |
| WO2007010283A8 (en) | Serine beta-lactamase-like / d-ala carboxypeptidase-like protein | |
| WO2001049839A3 (en) | Method for expressing gene and use thereof | |
| WO2004009633A8 (en) | Serotonin receptor | |
| WO2005116061A3 (de) | Sequenzen für die synthese antibakteriell wirkender polyketide |